Retrospective Evaluation of Acute Kidney Injury After Zoledronic Acid Administration to Dogs With Malignant Osteolysis

Zoledronic acid (ZOL) is an intravenous bisphosphonate indicated for the use of hypercalcemia of malignancy and management of bony metastases. Its therapeutic effect lies in the targeting of malignant osteoclasts; however, administration can be associated with renal toxicity. The objective of this r...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidal, Sarah A., Skorupski, Katherine A., Willcox, Jennifer L., Palm, Carrie A., Burton, Jenna H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282816/
https://www.ncbi.nlm.nih.gov/pubmed/34277751
http://dx.doi.org/10.3389/fvets.2021.647846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282816/
https://www.ncbi.nlm.nih.gov/pubmed/34277751
http://dx.doi.org/10.3389/fvets.2021.647846

Ejemplares similares